GlassScriptPhysician profile
Baher A Basta
NPI 1538130257
$557.05
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.77 · 2020: $52.83 · 2022: $186 · 2023: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171 · Education: $72.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.06 |
| Education | $72.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $91.54 | 2023 | Tavneos |
| Otsuka America Pharmaceutical, INC. | $77.53 | 2023 | Jynarque |
| Astrazeneca Pharmaceuticals LP | $77.32 | 2022-2023 | Lokelma |
| Mallinckrodt Enterprises LLC | $62.27 | 2019 | |
| Calliditas Therapeutics US INC. | $51.28 | 2022 | |
| Mallinckrodt Hospital Products INC. | $49.99 | 2022-2023 | Acthar |
| Axonics, INC. | $36.56 | 2020-2022 | |
| Novo Nordisk INC | $29.37 | 2022-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $20.97 | 2022 | |
| Akebia Therapeutics INC | $19.47 | 2022 | |
| Boston Scientific Corporation | $15.59 | 2020 | |
| Medtronic USA, INC. | $12.66 | 2020 | |
| Pfizer INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baher Basta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.